A comparison of 7 commercial anti-SARS-CoV-2 antibody immunoassays

INTRODUCTION: Serological testing in SARS-CoV-2 infection is gaining both patients’ and clinicians’ attention. Antibody assessment has potential multidirectional utility, hampered by the scarcity of clinical validation studies of the tests available on the market. Therefore, this study aimed to prov...

Descripción completa

Detalles Bibliográficos
Autores principales: Swadźba, Jakub, Bednarczyk, Maciej, Anyszek, Tomasz, Martin, Emilia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507786/
https://www.ncbi.nlm.nih.gov/pubmed/37732068
http://dx.doi.org/10.5114/aoms.2020.98361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507786/
https://www.ncbi.nlm.nih.gov/pubmed/37732068
http://dx.doi.org/10.5114/aoms.2020.98361

Ejemplares similares